| MS&T Expansion Lead RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Jul 31, 2024 |
| Associate, SCM Planner, RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Jul 31, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior Sales Representative - Ophthalmology |
Mapletree Business City (MBC) |
Singapore |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Third Party Risk Management Specialist |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| County Executive |
Maoming (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Product Specialist |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 30, 2024 |
| Global Procurement Category Manager, Chemicals |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
Jul 29, 2024 |
| Government Affairs Manager |
Moscow (City) |
Russian Fed. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Jul 29, 2024 |
| Clinical Development Medical Manager |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Jul 29, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 28, 2024 |
| 区域市场组经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
Jul 28, 2024 |
| Specialist - Master Data Management |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
Jul 26, 2024 |
| Senior Data/Software Engineer |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
Jul 26, 2024 |
| Sourcing Manager R&D |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
Jul 26, 2024 |
| MR |
Wuhu (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Jul 26, 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
Jul 25, 2024 |
| Medical Science Liaison Neuro |
Ekaterinburg |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
Jul 25, 2024 |